» Authors » Yuko Yoshida

Yuko Yoshida

Explore the profile of Yuko Yoshida including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 163
Citations 2166
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshida Y, Shinomiya A, Oikawa M, Shimada T, Hanaki K, Watanabe Y
Yakugaku Zasshi . 2025 Mar; 145(3):183-188. PMID: 40024730
Neonatal malnutrition has been suggested as a factor contributing to neurological and other disorders. However, the details of this mechanism remain unclear. We focused on fibroblast growth factor 21 (FGF21),...
2.
Yoshida Y, Ueki K, Matsukuma Y, Tsuchimoto A, Ataka E, Okamoto H, et al.
CEN Case Rep . 2024 Dec; PMID: 39733185
Neuron-derived neurotrophic factor (NDNF) was discovered as a target antigen in membranous nephropathy (MN) caused by syphilis. However, there have been few reports of NDNF-positive MN in Japan. A 19-year-old...
3.
Yamamoto T, Yoshida Y, Ose T, Murata Y, Hayashi T, Higo N
J Comp Neurol . 2024 Oct; 532(10):e25678. PMID: 39439015
Cerebellar molecular signatures in primates remain largely unexplored. Here, we investigated the immunoreactivity of neuroplasticity-related molecular markers, including aldolase C (Aldoc), phospholipase C beta 3 (PLCB3), and phospholipase C beta...
4.
Nishimura T, Mizokami R, Yamanaka M, Takahashi M, Yoshida Y, Ogawa Y, et al.
Biochem Biophys Res Commun . 2024 Oct; 735:150842. PMID: 39427376
Ezrin is a cross-linker protein between membrane proteins and cytosolic actin, abundantly expressed in the placenta among the ERM protein family. Ezrin gene knockout mice exhibit fetal growth restriction after...
5.
Inomoto A, Kanzaki R, Suzuki Y, Hiroshige K, Yotsumoto T, Yoshida Y, et al.
J Phys Ther Sci . 2024 Oct; 36(10):603-608. PMID: 39354933
[Purpose] Using new diagnostic criteria, this study aimed to clarify the relationship between respiratory sarcopenia and respiratory muscle weakness in community-dwelling older adults. [Participants and Methods] Basic information, body composition,...
6.
Yoshida Y, Ishizaki T, Masui Y, Miura Y, Matsumoto K, Nakagawa T, et al.
Arch Gerontol Geriatr . 2024 Jun; 126:105521. PMID: 38878595
Background: We prospectively examined the effect of baseline multimorbidity and polypharmacy on the physical function of community-dwelling older adults over a three-year period. Methods: The analysis included 1,401 older adults...
7.
Yoshida Y, Hirakawa Y, Hong Y, Mamun M, Shimizu H, Nakano Y, et al.
Home Health Care Serv Q . 2024 Mar; 43(4):239-258. PMID: 38521999
Systematic assessments of interprofessional collaboration barriers and enablers in long-term care settings are critical for delivering person-centered healthcare. However, research on factors influencing interprofessional collaboration in long-term care settings is...
8.
Takahashi S, Watanabe K, Fukuda S, Yoshida T, Dohmen T, Fujiwara J, et al.
Cancers (Basel) . 2024 Feb; 16(4). PMID: 38398125
Background: Since gastric cancers (GCs) detected after () eradication present with different morphological characteristics from conventional -positive GCs, delayed detection of early-stage GCs may be observed. This study aimed to...
9.
Iwasa H, Yoshida Y, Ishii K
Behav Sci (Basel) . 2024 Feb; 14(2). PMID: 38392459
This study explored the association of spousal support and marital satisfaction with the subjective well-being of fathers and mothers using a mediation analysis. Data were gathered from 360 fathers and...
10.
Kim Y, Ajiki T, Ueda Y, Yoshida Y, Takahashi T, Fukuyama H, et al.
Anticancer Res . 2024 Feb; 44(2):613-619. PMID: 38307557
Background/aim: Cell-free and concentrated ascites reinfusion therapy (CART) was established for refractory ascites and renovated CART (Keisuke Matsusaki (KM) -CART) has been recently developed especially for malignant ascites; however, the...